Showing 301-310 of 8859 results for "".
CSF After Dark
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/csf-after-dark/20386/ICYMI: Updates from behind the scenes at the 10th Annual Cosmetic Surgery Forum.Paying Across the Miles: Telehealth Reimbursement and the Dermatology Access Gap
https://practicaldermatology.com/topics/practice-management/paying-across-the-miles-telehealth-reimbursement-and-the-dermatology-access-gap/20327/Consistent reimbursement for telemedicine will improve access to care in rural areas.Four Ways to Ease the Burden of Prior Authorization
https://practicaldermatology.com/topics/practice-management/four-ways-to-ease-the-burden-of-prior-authorization/20434/There's no way around PAs, but it is possible to make the process more manageable.The Return of Patient-Centered Acne Care
https://practicaldermatology.com/topics/practice-management/the-return-of-patient-centered-acne-care/20528/With acne, it's not always the “what” that's most critical, it's often the “how.”The Year in Aesthetics
https://practicaldermatology.com/topics/practice-management/the-year-in-aesthetics/20399/A look at innovations and approvals in cosmetic dermatology in 2017.Make Some Noise: Advocating for Access
https://practicaldermatology.com/topics/practice-management/make-some-noise-advocating-for-access/20401/DCAN seeks to improve access to dermatologic treatments.High-Dose Ipilimumab Shows Benefits in Advanced Melanoma: Implications for Care
https://practicaldermatology.com/topics/skin-cancer-photoprotection/high-dose-ipilimumab-shows-benefits-in-advanced-melanoma-implications-for-care/20687/Although treatment is associated with a high rate of toxicity, survival benefit is extended at a higher dose.A Non-Invasive 2-Gene Molecular Assay Shows Promise in Assessment of Pigmented Lesions
https://practicaldermatology.com/topics/skin-cancer-photoprotection/a-non-invasive-2-gene-molecular-assay-shows-promise-in-assessment-of-pigmented-lesions/20705/More studies are needed, but a non-invasive assay that identified melanoma gene expression could support clinical decision making.Open Access: Thoughts for the Ballot Box
https://practicaldermatology.com/topics/practice-management/open-access-thoughts-for-the-ballot-box/20908/Access to drugs, derms at stake in US presidential election.Of Mips and Tucks: Making Sense of the Latest Serving of CMS' Alphabet Soup
https://practicaldermatology.com/topics/practice-management/of-mips-and-tucks-making-sense-of-the-latest-serving-of-cms-alphabet-soup/20989/Get your acronyms in order with this handy guide.